Sphere Fluidics
https://www.spherefluidics.com
Sphere Fluidics is a life sciences company, based in Cambridgeshire, UK and New Jersey, USA. Sphere Fluidics offers a novel platform (Cyto-Mine®) that performs single cell analysis.
Cyto-Mine® reduces costs for biopharmaceutical discovery and development. It is being adapted to single cell engineering using synthetic biology or genome editing.
In the media
11th December 2019
From time to time we receive great success stories from your region, let us know if you are interested by selecting one or more boxes below:
They were closely followed by the Cambridge-based Sphere Fluidics, whose introduction of a bespoke Trade Secrets policy in 2019 has significantly increased the sophistication of their overall IP strategy. The IP100 is backed
11th December 2019
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
SPERA MEDICAL SPHERE FLUIDICS LTD. STILLA TECHNOLOGIES STRAND LIFE SCIENCES PVT. LTD. STRATOS GENOMICS INC. SYAPSE SYSMEX INOSTICS GMBH TAI DIAGNOSTICS INC. TAKARA BIO
11th December 2019
Gerresheimer opens a new plant for the production of pharmaceutical primary plastic packaging in China
News and Press Releases Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK New offices at leading science hub support